These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 15649725)
21. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients. Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119 [TBL] [Abstract][Full Text] [Related]
22. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement. Lippi G; Franchini M; Targher G; Poli G; Guidi GC Clin Chim Acta; 2007 Jun; 381(2):167-70. PubMed ID: 17433810 [TBL] [Abstract][Full Text] [Related]
23. Platelets' glycoproteins and their ligands in patients with intermittent claudication. Gosk-Bierska I; Adamiec R; Szuba A Int Angiol; 2003 Jun; 22(2):164-71. PubMed ID: 12865882 [TBL] [Abstract][Full Text] [Related]
24. Onset of peripheral arterial disease: role of endothelin in endothelial dysfunction. de Haro Miralles J; Gónzalez AF; Varela Casariego C; García FA Interact Cardiovasc Thorac Surg; 2010 May; 10(5):760-5. PubMed ID: 20154344 [TBL] [Abstract][Full Text] [Related]
25. Effect of oral anticoagulant therapy on thrombospondin-1 and von Willebrand factor in patients with stable heart failure. Vila V; Sales VM; Almenar L; Lázaro IS; Villa P; Reganon E Thromb Res; 2008; 121(5):611-5. PubMed ID: 17692904 [TBL] [Abstract][Full Text] [Related]
26. Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Hergesell O; Andrassy K; Nawroth P Thromb Haemost; 1996 Jun; 75(6):892-8. PubMed ID: 8822582 [TBL] [Abstract][Full Text] [Related]
27. Exercise in patients with intermittent claudication elicits signs of inflammation and angiogenesis. Palmer-Kazen U; Religa P; Wahlberg E Eur J Vasc Endovasc Surg; 2009 Dec; 38(6):689-96. PubMed ID: 19775917 [TBL] [Abstract][Full Text] [Related]
28. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098 [TBL] [Abstract][Full Text] [Related]
29. Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease. Dalgård C; Nielsen F; Morrow JD; Enghusen-Poulsen H; Jonung T; Hørder M; de Maat MP Br J Nutr; 2009 Jan; 101(2):263-9. PubMed ID: 18507878 [TBL] [Abstract][Full Text] [Related]
30. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina. Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165 [TBL] [Abstract][Full Text] [Related]
31. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease. Unlü Y; Karapolat S; Karaca Y; Kiziltunç A Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391 [TBL] [Abstract][Full Text] [Related]
32. Markers of inflammation in relation to long-term cardiovascular mortality in patients with lower-extremity peripheral arterial disease. Urbonaviciene G; Frystyk J; Flyvbjerg A; Urbonavicius S; Henneberg EW; Lindholt JS Int J Cardiol; 2012 Oct; 160(2):89-94. PubMed ID: 21463908 [TBL] [Abstract][Full Text] [Related]
33. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication. Collins P; Ford I; Ball D; Macaulay E; Greaves M; Brittenden J Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):266-73. PubMed ID: 16360327 [TBL] [Abstract][Full Text] [Related]
34. Periodontitis is characterized by elevated PAI-1 activity. Bizzarro S; van der Velden U; ten Heggeler JM; Leivadaros E; Hoek FJ; Gerdes VE; Bakker SJ; Gans RO; Ten Cate H; Loos BG J Clin Periodontol; 2007 Jul; 34(7):574-80. PubMed ID: 17535288 [TBL] [Abstract][Full Text] [Related]
35. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients. Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Divecha H; Sattar N; Rumley A; Cherry L; Lowe GD; Sturrock R Clin Sci (Lond); 2005 Aug; 109(2):171-6. PubMed ID: 15801904 [TBL] [Abstract][Full Text] [Related]
37. Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity. Tayebjee MH; Tan KT; MacFadyen RJ; Lip GY J Intern Med; 2005 Jan; 257(1):110-6. PubMed ID: 15606382 [TBL] [Abstract][Full Text] [Related]
38. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. Lee KW; Blann AD; Lip GY Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758 [TBL] [Abstract][Full Text] [Related]
39. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients. Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415 [TBL] [Abstract][Full Text] [Related]
40. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Takahagi S; Mihara S; Iwamoto K; Morioke S; Okabe T; Kameyoshi Y; Hide M Allergy; 2010 May; 65(5):649-56. PubMed ID: 19845571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]